Flavia Eliana Santiano

Flavia Eliana Santiano

Auto-generated profile, based on publicly available information

Flavia Eliana Santiano

Laboratory of Hormones and Cancer Biology Institute of Medicine and Experimental Biology of Cuyo (IMBECU), National Scientific and Technical Research Council (CONICET UNCuyo) Mendoza Argentina

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 February 2017 in Journal of Experimental & Clinical Cancer Research
Verified
Journal Article
Open access
PDF file
SFSabrina Johanna Fletcher
Sabrina Johanna Fletcher
PSPaula Sacca
Paula Sacca
MPMercedes Pistone-Creydt
Mercedes Pistone-Creydt
FCFederico Andrés Coló
Federico Andrés Coló
MSMaría Florencia Serra
María Florencia Serra
VPVirginia Pistone-Creydt
Virginia Pistone-Creydt
Adipose microenvironment is involved in signaling pathways that influence breast cancer. We aim to characterize factors that are modified: 1) in tumor and non tumor human breast epithelial cell lines when incubated with conditioned media (CMs) from human breast cancer adipose tissue explants (hATT) or normal breast adipose tissue explants (hATN); 2) in hATN-CMs vs hATT-CMs; 3) in the tumor associated adipocytes vs. non tumor associated adipocytes. We used hATN or hATT- CMs on tumor and non-tumor breast cancer cell lines. We evaluated changes in versican, CD44, ADAMTS1 and Adipo R1 expression on cell lines or in the different CMs. In addition we evaluated changes in the morphology and expression of these factors in slices of the different adipose tissues. The statistical significance between different experimental conditions was evaluated by one-way ANOVA. Tukey’s post-hoc tests were performed within each individual treatment. hATT-CMs increase versican, CD44, ADAMTS1 and Adipo R1 expression in breast cancer epithelial cells. Furthermore, hATT-CMs present higher levels of versican expression compared to hATN-CMs. In addition, we observed a loss of effect in cellular migration when we pre-incubated hATT-CMs with chondroitinase ABC, which cleaves GAGs chains bound to the versican core protein, thus losing the ability to bind to CD44. Adipocytes associated with the invasive front are reduced in size compared to adipocytes that are farther away. Also, hATT adipocytes express significantly higher amounts of versican, CD44 and Adipo R1, and significantly lower amounts of adiponectin and perilipin, unlike hATN adipocytes. We conclude that hATT secrete a different set of proteins compared to hATN. Furthermore, versican, a proteoglycan that is overexpressed in hATT-CMs compared to hATN-CMs, might be involved in the tumorogenic behavior observed in both cell lines employed. In addition, we may conclude that adipocytes from the tumor microenvironment show a less differentiated state than adipocytes from normal microenvironment. This would indicate a loss of normal functions in mature adipocytes (such as energy storage), in support of others that might favor tumor growth.

29 December 2022 in Nutrition
Verified
Journal Article
Closed access
FSFlavia E. Santiano
Flavia E. Santiano
MFMaría de Los Ángeles Fernández
María de Los Ángeles Fernández
MEMagdalena Espino
Magdalena Espino
LZLeila E. Zyla
Leila E. Zyla
LRLara Rey
Lara Rey
CFConstanza Matilde Matilde López Fontana
Constanza Matilde Matilde López Fontana

1 June 2019 in Molecular and Cellular Endocrinology
Verified
Journal Article
Closed access
CFConstanza Matilde Matilde López Fontana
Constanza Matilde Matilde López Fontana
GPG. Pennacchio
G. Pennacchio
LZL.E. Zyla
L.E. Zyla
JTJ. Toneatto
J. Toneatto
FBF.A. Bruna
F.A. Bruna
RCR.W. Carón
R.W. Carón

1 January 2014 in BioMed Research International
Verified
Journal Article
Open access
PDF file
CSCorina V. Sasso
Corina V. Sasso
FSFlavia E. Santiano
Flavia E. Santiano
CLConstanza M. López-Fontana
Constanza M. López-Fontana
VPVirginia Pistone-Creydt
Virginia Pistone-Creydt
MEMarcelo Ezquer
Marcelo Ezquer
RCRubén W. Carón
Rubén W. Carón
Prolactin (PRL) is a key player in the development of mammary cancer. We studied the effects of parity or hyperprolactinemia on mammary carcinogenesis in OFA hr/hr treated with 7,12-dimethylbenzanthracene. They were divided into three groups: nulliparous (Null), primiparous (PL, after pregnancy and lactation), and hyperprolactinemic rats (I, implanted in the arcuate nucleus with 17β-estradiol). The tumor incidence was similar in the three groups. However, a higher percentage of regressing tumors was evident in the PL group. Serum PRL, mammary development, and mammaryβ-casein content were higher in I rats compared to Null. The expression of hormone receptors was similar in the different groups. However, mammary tissue from PL rats bearing tumors had increased expression of PRL and estrogen alpha receptors compared to rats free of tumors. Our results suggest that serum PRL levels do not have relevance on the incidence of tumors, probably because the low levels of PRL in OFA rats are not further decreased by PL like in other strains. However, supraphysiological levels of PRL affect carcinogenesis. PL induces regression of the tumors due to the differentiation produced on the mammary cells. Alterations in the expression of hormonal receptors may be involved in progression and regression of tumors.

6 March 2023 in Acta Paediatrica
Verified
Journal Article
Closed access
FSFlavia Eliana Santiano
Flavia Eliana Santiano
JFJuan Manuel Fernandez‐Muñoz
Juan Manuel Fernandez‐Muñoz
VPVirginia Pistone‐Creydt
Virginia Pistone‐Creydt
FZFelipe Carlos Martín Zoppino
Felipe Carlos Martín Zoppino
CLConstanza Matilde López‐Fontana
Constanza Matilde López‐Fontana
RCRubén Walter Carón
Rubén Walter Carón